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ABSTRACT
Background: With advanced age, there is increased risk of various infections. Antimicrobial
agents are majorly prescribed for management of these infections. Due to age-related physiological
changes, many of the antimicrobial agents cause adverse mental health. Therefore, we evaluated
the geriatric antimicrobial prescription to determine its potential to cause mental health issue.

Objectives:


To prepare a checklist for antimicrobials which have the potential to cause adverse
mental health.
 Evaluate the geriatric antimicrobial prescription to determine its potential to cause mental
health issue.
 To determine antimicrobial-related mental health problems in geriatric patients.

Methods: A prospective observational study was conducted in all the medicine departments of
Kasturba Hospital (KH), Manipal. The geriatric patients prescribed with antimicrobial agents were
recruited based on the inclusion and exclusion criteria. A checklist of antimicrobial agents with
potential to develop adverse mental health was prepared by performing thorough literature review
and hospital formulary of KH, Manipal. All the relevant data was collected in the case report form
and the potential agents that could cause adverse mental health were identified using the checklist.
The data was entered in IBM SPSS version 25.0 and suitable descriptive statistical analysis was
carried out.

Results: Out of the 115 geriatric patients, 89 (77.4%) were prescribed with a total of 178
antimicrobial agents with potential to develop adverse mental health. Average number of
antimicrobials per prescription, which has the potential to cause mental health adverse effect is
1.5. These prescriptions comprised of 21 drugs from various classes of antimicrobial agents listed
in the checklist prepared. Out of the 89 patients who received the antimicrobials with potential to
cause the adverse mental health, 10 patients developed the adverse drug reactions such as
insomnia, agitation, delirium, anxiety, nightmares, and seizures. Female geriatric patients have 3.5
times higher risk for developing the adverse mental health problems compared to male patients
after the antimicrobial use (OR: 3.5; 95% CI:0.06-1.41). However, the risk for development of
adverse mental health problems in patients with renal dysfunction are 28% times less likely than
the patients with normal renal function (OR: 0.28; 95% CI:0.08-6.15).

Conclusions:
The major antimicrobial classes, which have adverse mental health issues in geriatrics are betalactams, tetracyclines, cephalosporins, fluoroquinolones, macrolides, sulfonamides,
aminoglycosides, carbapenems, oxazolidines, other antibiotics, antifungals, antimalarial and
antivirals. Risk estimation shows that women geriatric patients have higher risk for developing the
adverse mental health problems compared to men after the antimicrobial use. However, unlike
other studies renal dysfunction was not found to be a risk factor for developing the adverse mental
health. Potential mechanism of toxicity differs among the agents and the etiology also remains
unidentified in some cases. However, the incidences may be increased due to presence of comorbidities, drug interaction and age-related changes.

INTRODUCTION
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1. INTRODUCTION
1.1 Increased Risk of Infection in Geriatrics
In majority of individuals aged 65 years and older, the primary cause of death is infection.
Infection may be caused due to compromised immunity. There are a few age-related
physiological changes which lead to infections in geriatrics:
 Due to alterations in barriers posed by gastrointestinal tract, lungs, and skin (and other
mucosal linings). There can be increased risk of pathogenic organisms’ invasion.
 Due to change in humoral and cellular immunity, decreased specific cell population,
decreased production of specific cytokines (e.g., Interleukin-2) and loss of
proliferative capacity of immune cells, there can be an increased risk of intracellular
pathogens.
 Due to impaired signal transduction after cytokine binding, there are chances of
impaired defense against fungal and viral pathogens.
 Reduction in receptors and cells like CD8 and CD4. There can be decrease in the
antibody response to vaccines.
 Due to reduction in naïve B cells, there can be impairment in immunoglobulin
production and specificity of antibody responses.
There is a greater impairment in immunity, which results in increased risk of infections and
poorer vaccine responses in geriatrics along with chronic diseases like, diabetes, chronic
obstructive pulmonary disease, or heart failure.
Geriatric patients living in communal residence such as daycare center or senior centers, have
a greater risk of infection.

1.2 Presentation of Disease in Geriatrics
It is difficult to identify infection in geriatrics, since the signs and symptoms in geriatrics can
be different to that of the typical signs and symptoms in younger adults. For example, in case
of infection, there may be lack of fever or localization, or specific infection signs and
symptoms. Similarly, in case of pneumonia, instead of fever, productive cough, chest pain, the
signs and symptoms seen can be low-grade fever and increased oxygen demand.
In geriatrics, the infections may be identified due to symptoms such as confusion, falling and
anorexia. But these symptoms are useful only for provisional diagnosis and based on that
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empiric treatment can be initiated after careful physical examination, medical review and
other diagnostic tests. However, once the diagnostic test results are negative, the empiric
treatment should be discontinued.

1.3 Antimicrobial Therapy
Antimicrobials are considered for management of infections, which are serious and lifethreatening, for example, sepsis, pneumonia, influenza, etc. Antimicrobial therapy in geriatrics
is determined by age-related pharmacokinetic (PK) changes and increased risk of exposure to
multi-drug resistant (MDR) organisms.

1.3.1 Choice of antimicrobial agent:
The choice of initial antimicrobial is same as in younger adults for most infections. However,
precautions must be taken when initiating broader empiric treatment in geriatrics as there is an
increased risk of infection with drug-resistant organisms. This can be because of recent
hospitalization, dialysis, recent antimicrobial treatment, indwelling devices or due to residence
in community center.
Seriously ill geriatric patients with conditions like pneumonia, sepsis or other life-threatening
infections are suspected, the broader initial coverage of antimicrobial may be appropriate.
However, it is important to narrow down the antimicrobial regimen when the cultures are
available to decrease the risk of antimicrobial resistance in the patient. It is also important to
consider the interactions of antimicrobial drugs and other drugs in geriatrics, especially the
drugs with narrow therapeutic index. Example, commonly seen interactions are for
antimicrobials with warfarin, digoxin, antacids, and H2-receptor antagonists. However, the
interaction is difficult to predict for some antimicrobials.

1.3.2 Dosing:
Dosing is very critical in geriatrics, as the PK parameters change in them due to age and comorbidities. For the antimicrobials to show its action, it is important to maintain the drug
levels in therapeutic range, thus, appropriate dosing is required. (1)
 Absorption: Due to increasing age, there can be changes in gastrointestinal tract, such
as, delayed gastric emptying, reduced splanchnic blood flow and alterations in pH. This
can affect the bioavailability of the drugs.
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 Distribution: The distribution can be affected due to increased adipose tissues in
geriatrics. This can lead to increased distribution of lipophilic drugs (For examples,
fluoroquinolone, macrolides, tetracyclines, antifungals, etc.) in tissue compartment, which
leads to increased half-life of lipid soluble drugs. Decrease in total body water and lean
mass decreases the solubility of water-soluble drugs in tissue compartment. This means
there an increase in the plasma concentration of water-soluble drugs, such as,
aminoglycosides, beta-lactams, etc. In such situation, loading dose of water-soluble drugs
is required when indicated in case of serious infections. Decrease in plasma albumin due
to various reasons can also increase the concentration of free drug in plasma, for example,
penicillin, ceftriaxone, sulfonamides, and clindamycin.
 Metabolism: Due to reduced hepatic blood flow or reduced hepatic function, as a result
of ageing or liver disease, the metabolism of hepatically metabolized antimicrobials will
be affected. It may increase the half-life of such drugs such as macrolides,
fluoroquinolones, azole antifungals, etc.
 Elimination: With increasing age, there is reduction in function of lungs, kidneys,
bladder, gastrointestinal tract, and circulatory system, which affects the elimination of drug
from the body. Thus, may lead to accumulation of drug in the body and cause toxicity.
Kidneys are essential for elimination of antimicrobials such as beta-lactams,
aminoglycosides, ciprofloxacin, levofloxacin, trimethoprim/sulfamethoxazole, etc. (2)

1.4 Mental Health in Geriatrics
Geriatric patients have major risk factors for drug-induced adverse mental health, which can
include advanced age, polypharmacy, underlying neurologic disorders, kidney impairment and
other co-morbidities. The adverse mental health effects can be observed in geriatrics due to
alterations

in

neurotransmission

and

signal

transduction,

changes

in

PK

and

pharmacodynamics (PD) changes and polypharmacy. Additionally, uremia can cause increase
in blood-brain barrier (BBB) penetration and decrease in albumin can cause increase in free
fraction of drugs. Certain co-morbidities, such as respiratory failure, heart failure or myocardial
infarction, can lead to change in oxygen and nutrient delivery to central nervous system (CNS),
may predispose to delirium. (3)
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1.5 Antimicrobial-Induced Adverse Mental Health in Geriatrics
1.5.1 Antibiotics
1.5.1.1 Penicillin
Among the penicillin agents, piperacillin and tazobactam are reported to have the most
neurotoxicity. Most cases are reported in patients with advanced renal insufficiency (creatinine
clearance <15 mL/min). Patients experience neurotoxic events such as seizures, convulsions,
hallucinations, confusion, disorientation, delirium, insomnia, and bizarre behavior. The onset
of symptoms is usually within 7 days of therapy initiation. There are several predisposing
conditions, such as advancing age, hypoalbuminemia, malnutrition, and inflammation. These
increase the risk of piperacillin and tazobactam accumulation in patients with renal
dysfunction. (4) Ampicillin have been reported to show adverse mental events like convulsions,
seizures, hallucinations, and mania. While amoxicillin is associated with agitation, anxiety,
confusion, insomnia, seizures, unusual behavior.

1.5.1.2 Tetracycline
Tetracycline agents are usually prescribed for atypical pneumonias, uncomplicated skin and
soft tissue infections, etc. Neurotoxicity is limited in this class. Doxycycline-induced insomnia
is commonly observed adverse mental health. (4)

1.5.1.3 Cephalosporin
Cephalosporins show various adverse mental health effects within all four generations. The
most frequent reports are seen in cefepime, ceftazidime, cefuroxime, and cefazolin. Commonly
observed adverse drug reactions (ADRs) for cefazolin and ceftazidime are encephalopathy and
seizures. Cephalexin and cefuroxime can cause seizures. While cefepime can cause confusion,
hallucinations, agitation, convulsion, and delirium. (4)
Renal impairment and excess dosage have increased risk of neurotoxicity with use of
cephalosporins, but it is also reported in patients with normal creatinine clearance. Typically,
the ADRs are seen within 10 days of initiation of regimen and resolve within 7 days after
discontinuation of the medication. (5)
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1.5.1.4 Fluoroquinolones
Fluoroquinolones are used as broad-spectrum antimicrobial agents in treatment of infectious
diseases. Since 2008, United States Food and Drug Administration (US FDA) mandated black
box warnings and package inserts which have been revised over the years. One of the warnings
include mental health side effects which are listed under CNS effects in the warnings and
precautions section of the drug label and is differed by individual drug. Owing to this, FDA
has advised to restrict the use of fluoroquinolones for some uncomplicated infections. (6)
Ciprofloxacin and moxiﬂoxacin have seen to cause psychosis, delirium, agitation, depression,
hallucinations, nightmares, and seizures. While levofloxacin was found to cause insomnia,
psychosis, delirium, agitation, depression, hallucinations, nightmares, and seizures.
Norfloxacin was reported to cause seizures, psychosis, and confusion.

1.5.1.5 Macrolides
Macrolides such as azithromycin, clarithromycin and erythromycin have been extensively used
in treatment of various infectious diseases such as sexually transmitted diseases (STDs),
respiratory tract infections (RTIs), peptic ulcers due to Helicobacter pylori and Mycobacterium
avium complex (MAC) infection. More commonly associated drug with neurotoxicity is
clarithromycin, however, azithromycin has been associated to cause delirium and erythromycin
to cause seizures. Anxiety, confusion, insomnia, psychosis, convulsions, disorientation,
hallucinations, mania, and seizures are associated with clarithromycin. (3,4)

1.5.1.6 Sulfonamides
Sulfonamides such as sulfasalazine and the combination of trimethoprim and sulfamethoxazole
provide bactericidal effect against many infectious diseases. These include the infections
caused by gram-positive and gram-negative bacilli, such as skin and soft tissue infections, RTIs
and urinary tract infection (UTI). Trimethoprim and Sulfamethoxazole are also used to prevent
many

opportunistic

infections

in

immune

compromised

diseases

like

human

immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS). The most
seen mental adverse effects of this combination include psychosis, agitation, seizures,
hallucinations, depression, and nervousness. While sulfasalazine is reported to cause
encephalopathy and seizures.
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1.5.1.7 Aminoglycosides
Aminoglycosides are mostly used in management of gram-negative infections. Gentamicin and
Tobramycin have been associated with psychosis, encephalopathy, seizure, delirium, confusion
and disorientation, while kanamycin with nervousness and restlessness and neomycin with
convulsions. (4)

1.5.1.8 Carbapenems
Carbapenems are primarily associated with seizures and seizure-like activity. This is also
mentioned in the FDA label. Imipenem-cilastatin was reported to cause seizures in elderly. The
incidence rate was 1.5% - 2% as per the post-marketing reports. Meropenem caused seizures,
delirium, and hallucinations. Ertapenem caused seizures, hallucinations, confusion,
disorientation, somnolence, aggression, delirium, and encephalopathy. (4,7)

1.5.1.9 Oxazolidinone
Post-marketing reports indicate growing trend of adverse mental health with linezolid such as
encephalopathy, seizure, and delirium.

1.5.1.10 Other Antibiotics
Several case reports outline that metronidazole caused encephalopathy, confusion,
disorientation, insomnia, seizure, and depression. Polymyxin caused confusion, hallucinations,
and seizures. Nitrofurantoin caused depression and confusion. A prospective cohort study
reported that advanced age was associated with isoniazid-induced adverse effects which
included encephalopathy, memory impairment, psychosis, and seizures. (4) Rifampin caused
confusion, somnolence, difficulty in concentration, psychotic disorder, and unusual change in
behaviour. Ethambutol caused hallucinations and mania.

1.5.2 Antifungal
Antifungal amphotericin B has been associated with dementia, confusion, and disorientation.(3)
The azole group of antifungals like fluconazole have been reported to cause seizures, while
ketoconazole has been associated with disorientation and somnolence.
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1.5.3 Antimalarial
Mefloquine has been reported to induce confusion, encephalopathy, insomnia, memory
impairment, seizure, somnolence, aggressive behaviour, agitation, anxiety, risk for suicide,
delirium, delusional disorder, depression, hallucinations, mania, mood swings, nightmares,
panic attack, phobia and psychotic disorder. Quinine has been reported to cause confusion and
restlessness. Primaquine has been associated with depression and psychotic disorder, while
chloroquine associated with seizures. (3)

1.5.4 Antiviral
Ganciclovir-induced encephalopathy and seizures have been observed in some case reports.
Acyclovir has been associated with confusion, dizziness, encephalopathy, seizure and
somnolence. (3)

1.6 Need for the study
With increase in the standard of medical care, there has been an increase in life expectancy of
human beings, leading to an increase in the geriatric population. The geriatric population is at
an increased risk of experiencing ADRs due to alterations in PK properties. This leads to
distortion in drug absorption, distribution, metabolism, elimination, and protein binding, which
increase the risk of ADR. With increase in age, the muscle mass decreases, and the body fat
can double, altering the PK changes of lipophilic drugs. They are also at an increased risk of
drug-induced adverse mental health issues due to alterations in neurotransmission and signal
transduction, changes in PK /PD, and increased medication burden.
Therefore, it is important that the geriatric prescription guidelines are to be followed strictly to
avoid the ADRs in geriatrics. Besides, majority of the studies conducted on safety of
antimicrobials on mental health in geriatrics were from Western population. Extrapolating that
data on Indian population may not be justified. Hence, we designed this study to evaluate the
use of antimicrobial drugs in geriatrics as per geriatric prescription guidelines and assess if
these drugs have any potential to develop adverse mental health in geriatric population.
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AIMS & OBJECTIVES
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2.1 AIM:
To study the antimicrobial agents’ usage in geriatric patients and mental health problems
related to these agents.

2.2 OBJECTIVES:


To prepare a checklist of drugs as per the hospital formulary, which have the potential
to cause adverse mental health.



Evaluate the geriatric antimicrobial prescription to determine its potential to cause
mental health issue.



To identify antimicrobial-related mental health problems in geriatric patients
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METHODOLOGY
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3. METHODOLOGY
3.1 Study Site: The study was conducted in all medicine units of Kasturba Medical
College Hospital, Manipal, a tertiary care hospital in South-India.

3.2 Study Design: Cross-sectional study.
3.3 Study Period: 8 months (August 2019 – March 2020)
3.4 Sample Size: 115 geriatric patients prescribed with antimicrobial agents during the
study period and admitted in the Medicine units of Kasturba Medical
College Hospital, Manipal.

3.5 Ethical Approval: The protocol for this study was approved by the Institutional
Ethical Committee of Kasturba Medical College and Kasturba
Hospital, Manipal. (IEC - 588/2019) [Appendix I]. Clinical Trial
Registry-India (CTRI) registration was taken (registration number
CTRI/2019/09/021420).

3.6 Study Criteria:
3.6.1 Inclusion:
 Geriatric patients (65 years and above)
 Patients of both gender
 Patients receiving antimicrobial drugs

3.6.2 Exclusion:
 Geriatric patients who have not been prescribed antimicrobial drugs
 Other than geriatric population
 Patients who have psychiatric disorder or on anti-psychotic drugs
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3.7 Data Source:
The study population broadly represents the South-Indian population. All relevant data was
obtained from the medical records of geriatric patients prescribed with antimicrobial agents
during the study period.

3.8 Study Material:
 Participant Information Sheet (PIS) - Used to provide necessary details (purpose,
benefits/risks, procedure) regarding the study [ Appendix II a, b].
 Informed Consent Form (ICF)– An Informed consent form in Kannada or English was
obtained from each participant/ Legally Authorized Representative before study
initiation [ Appendix III a, b].
 Case Report Form (CRF) - To collect patient data (demographics, past medical
history, diagnosis, treatment regimen, lab data & other clinical investigations)
[Appendix IV].

3.9 Operation Modality:
The study was carried out in the following steps:
Step 1: Preparing the checklist for the antimicrobial agents
Step 2: Designing the data collection form or case report form
Step 3: Data collection
Step 4: Data entry
Step 5: Evaluation and analysis

Step 1: Preparing the checklist for list of antimicrobial agents
A checklist of antimicrobial agents was prepared to list down all the potential drugs that cause
adverse mental health in geriatrics. A thorough literature review was done on antimicrobial
agents causing adverse mental health in geriatrics. Only four main categories of antimicrobial
drugs were included, namely, antibiotics, other antibiotics (anaerobic agents, antimycobacterial), antifungals and antivirals (expect anti-HIV agents). An inclusion criterion was
made based on the antimicrobials available in the Kasturba Hospital’s hospital formulary.
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Step 2: Designing the data collection form or case report form
As per the requirement of study protocol, a data collection form was made to include all the
relevant data. Date such as the patient demographics, past medical history, medication history,
co-morbidities, previous exposure to antimicrobials, diagnosis, lab data, treatment regimen,
adverse effects seen and other relevant clinical data.

Step 3: Data collection
Geriatric patients (65 years and above) of both genders were prospectively identified in all the
medicine departments of Kasturba Medical College Hospital, who were prescribed with antimicrobial agents. Based on the inclusion and exclusion criteria, participants were recruited after
they or their legal representatives (in unconscious patients) have been explained about the study
in detail via using a participation Information sheet and then obtaining their informed consent.
All the relevant data from patient’s medical record was collected in the case report form.

Step 4: Data entry
The data was entered in statistical package for the social sciences (SPSS) version 25.0 for the
data analysis.

Step 5: Evaluation and analysis:
Suitable descriptive statistical analysis was carried. Nominal data were expressed as frequency
and percentage and continuous variables using descriptive statistics (Mean ± Standard
Deviation).
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All In-patients
admitted to Medicine
units of KMC
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• Screened for
Antimicrobial
prescriptions
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Antimicrobial
prescriptions

• Inclusion and
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criteria

Suitable patients with
Antimicrobial
prescription

Yes

• Checked for
potential
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health effect as
per the
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No

ADR seen
as per the
checklist

Yes

No

Figure 1: Study Flow Chart
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4. RESULTS
4.1 Developed Checklist of Antimicrobial Agents with Potential Adverse
Mental Health
A checklist was prepared which consisting of antimicrobial agents that have potential to
develop adverse mental health [Table 1]. The checklist was developed by thorough literature
review using key words “adverse mental health”, “antimicrobials”, “antibiotics”, etc. and
by referring hospital formulary of Kasturba Hospital, Manipal.

Table 1: Checklist of Antimicrobials with Potential to Cause Adverse Mental Health
Sl. No.
I

Drugs

a
b

Antibiotics
Penicillin
Ampicillin
Piperacillin/ tazobactam

c

Amoxicillin

1)

2)
a
b
3)
a
b
c
d
e

TetracyclineDoxycycline
Minocycline
Cephalosporin
Cefazolin
Cephalexin
Ceftazidime
Cefepime

a

Cefuroxime
Fluoroquinolones
Ciprofloxacin

b

Levoﬂoxacin

c

Moxiﬂoxacin

d

Norfloxacin
Macrolide
Azithromycin

4)

5)
a

Adverse Mental Health

Convulsions, Hallucinations, Mania, Seizures
Behavior Bizarre, Confusion, Convulsions,
Delirium, Disorientation, Hallucinations,
Insomnia, Seizures
Agitation, Anxiety, Confusion, Insomnia,
Seizures, Unusual Behavior
Insomnia, Suicidal Thoughts
Depersonalization, Somnolence
Encephalopathy, Seizures
Seizures
Encephalopathy, Seizures
Agitation, Confusion, Convulsion, Delirium,
Hallucinations
Seizures
Agitation, Delirium, Depression,
Hallucinations, Nightmares, Psychosis,
Seizures
Agitation, Delirium, Depression,
Hallucinations, Insomnia, Nightmares,
Psychosis, Seizures
Agitation, Delirium, Depression,
Hallucinations, Nightmares, Psychosis,
Seizures
Confusion, Psychosis, Seizures
Delirium
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b

Clarithromycin

c

Erythromycin
Sulfonamides
SulfamethoxazoleTrimethoprim
Sulfasalazine
Aminoglycosides
Gentamicin
Tobramycin

6)
a
b
7)
a
b
c
d
8)
a
b
c

9)

Kanamycin
Neomycin
Carbapenems
Imipenem-Cilastatin
Meropenem
Ertapenem

a

Oxazolidinone
Linezolid
Other antibiotics
Metronidazole

b
c
d

Polymyxin
Nitrofurantoin
Isoniazid

e

Rifampin

f

a
b

Ethambutol
Antifungal
Amphotericin B
Fluconazole
Ketoconazole
Antimalarial
Quinine
Mefloquine

c
d

Primaquine
Chloroquine

a
II

III
a
b
c
IV

Anxiety, Confusion, Convulsions,
Disorientation, Hallucinations, Insomnia,
Mania, Psychosis, Seizures
Seizures
Agitation, Depression, Hallucinations,
Nervousness, Psychosis, Seizures
Encephalopathy, Seizures
Delirium, Encephalopathy, Psychosis, Seizure
Confusion, Delirium, Disorientation,
Psychosis
Nervousness, Restlessness
Convulsions
Seizures
Delirium, Hallucinations, Seizures
Aggression, Confusion, Delirium,
Disorientation, Encephalopathy,
Hallucinations, Seizures, Somnolence
Delirium, Encephalopathy, Seizure
Confusion, Depression, Disorientation,
Encephalopathy, Insomnia, Seizure
Confusion, Hallucinations, Seizures
Confusion, Depression
Disturbance, Encephalopathy, Hallucinations,
, Lethargy, Memory Impairment, Paranoia,
Psychosis, Seizures, Sleep
Confusion, Psychotic Disorder, Somnolence,
Unable to concentrate, Unusual change in
behaviour
Hallucinations, Mania
Confusion, Dementia, Disorientation
Insomnia, Seizure, Somnolence
Disorientation, Somnolence
Confusion, Restlessness
Aggressive behaviour, Agitation, Anxiety,
Confusion, Delirium, Delusional disorder,
Depression, Encephalopathy, Hallucinations,
Insomnia, Mania, Memory impairment, Mood
swings, Nightmares, Panic attack, Phobia,
Psychotic disorder, Risk for suicide, Seizure,
Somnolence
Depression, Psychotic disorder
Seizure
Page | 18

V
a
b

Antiviral
Ganciclovir
Acyclovir

c
d

Valganciclovir
Oseltamivir

Encephalopathy, Seizure
Confusion, Dizziness, Encephalopathy,
Seizure, Somnolence
Depression, insomnia, anxiety
Delirium, Delusions, Hallucinations,
Nightmares, Suicidality,
Confusion, Disturbance of Consciousness,
Seizure, Mania, Anxiety

4.2 Demographic Details of the Geriatric Patients
A total number of 115 patients were taken from all the Medicine units of Kasturba Medical
College Hospital, Manipal, during the period October 2019 to February 2020. 51 (44.3%)
were males and 64 (55.7%) were females [ Table 2].

Table 2: Demographic Details of the Geriatric Patients
Patient Demographics
Age (Mean ± SD) [years]
Gender:
Male
Female
Duration of Hospitalization (Mean ± SD) [days]
Alcoholic
Yes
No
Smoking
Yes
No
No. of Co-morbidities (Mean ± SD)

No of patients (%) / Mean± SD
71.90 ± 6.186
51 (44.3%)
64 (55.7%)
11.82 ± 6.962
16 (13.9%)
99 (86.1%)
8 (7.0%)
107 (93%)
1.74 ± 1.332
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4.3 Indication for Antimicrobial agents in the Patients
Out of total 115 geriatric patients, 45 (39.1%) patients received empirical antimicrobial
therapy while, 70 (60.9%) received definitive therapy of antimicrobial agents.

Figure 2: Indication for Antimicrobial Agents in the patients

4.4 Conditions for Antimicrobial Agent Prescription in Geriatric Patients
Out of 115 patients who received different antimicrobials, 25 (21.73%) were have
pneumonia, 21(18.26%) were have lower respiratory tract infections (LRTI) and 11 (9.56%)
were have UTI [ Table 3].
Table 3: Conditions for Antimicrobial Prescribed in Geriatric Patients
Conditions

No. of Patients (%)

Pneumonia

25 (21.73%)

LRTI

21 (18.26%)

UTI

11 (9.56%)

Urosepsis

9 (7.82%)

Suspected infections

13 (11.3%)

Others

36 (31.3%)
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4.5 Combination of Antimicrobial agents prescribed in the Patients
The geriatric patients were prescribed antimicrobial agents either as monotherapy (39;
33.9%) or as combination (76; 66.1%) [Table 4]. Total 265 drugs were prescribed to 115
patients.

Table 4: Combination of Antimicrobial Agents prescribed
No. of drugs in combination of Antimicrobials

No. of Patients (%)

Two antimicrobial agents

34 (29.6%)

Three antimicrobial agents

25 (21.7%)

Four antimicrobial agents

9 (7.8%)

Five antimicrobial agents

3 (2.6%)

Six antimicrobial agents

3 (2.6%)

Seven antimicrobial agents

2 (1.7%)

Table 5: List of Antimicrobial agents prescribed to the study population
Antimicrobial Agents

No. of Patients (%)

Cefuroxime
Ceftriaxone
Piperacillin/Tazobactam
Amoxicillin
Clindamycin
Azithromycin + Oseltamivir + Cefuroxime + Ceftriaxone

7 (6.1)
7 (6.1)
3 (2.6)
2 (1.7)
2 (1.7)
1 (0.9)

Azithromycin + Oseltamivir + Piperacillin / Tazobactam

4 (3.5)

Azithromycin + Cefuroxime + Piperacillin / Tazobactam

2 (1.7)

Clindamycin + Piperacillin / Tazobactam
Ceftriaxone + Metronidazole
Azithromycin + Oseltamivir + Piperacillin / Tazobactam +
Levofloxacin + Amoxicillin / Clavulanic acid

5 (4.3)
2 (1.7)
1 (0.9)

Clindamycin + Amoxicillin / Clavulanic acid

1 (0.9)

Oseltamivir + Piperacillin / Tazobactam
Cefixime
Ceftriaxone+ Clindamycin+ Cefoperazone / Sulbactam

2 (1.7)
1 (0.9)
1 (0.9)
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Isoniazid+ Rifampin+ Ethambutol+ Pyrazinamide

1 (0.9)

Azithromycin+ Ceftriaxone+ Metronidazole+ Isoniazid+
Rifampin+ Ethambutol+ Pyrazinamide

1 (0.9)

Metronidazole + Piperacillin / Tazobactam

1 (0.9)

Cefoperazone / Sulbactam
Ceftriaxone+ Doxycycline
Azithromycin+ Doxycycline+ Oseltamivir+ Piperacillin /
Tazobactam
Cefepime
Doxycycline
Azithromycin+ Ceftriaxone+ Piperacillin / Tazobactam

10 (8.7)
3 (2.6)
1 (0.9)

Ceftriaxone+ Imipenem/ Cilastatin+ Piperacillin / Tazobactam

1 (0.9)

Clindamycin+ Doxycycline+ Meropenem/Sulbactam+
Piperacillin/ Tazobactam+ Teicoplanin+ Vancomycin

1 (0.9)

Azithromycin+ Ceftriaxone+ Oseltamivir+ Cefazolin+
Linezolid+ Doxycycline+ Vancomycin

1 (0.9)

Azithromycin+ Ceftriaxone
Azithromycin+ Doxycycline+ Piperacillin / Tazobactam

6 (5.2)
1 (0.9)

Azithromycin+ Ceftriaxone+ Oseltamivir
Cefoperazone/ Sulbactam+ Meropenem/ Sulbactam

6 (5.2)
1 (0.9)

Ceftriaxone+ Levofloxacin+ Oseltamivir
Clindamycin+ Meropenem / Sulbactam
Azithromycin+ Ceftriaxone+ Oseltamivir+ Piperacillin /
Tazobactam
Azithromycin+ Amoxicillin/ Clavulanic acid+ Piperacillin/
Tazobactam+ Meropenem/ Sulbactam

1 (0.9)
1 (0.9)
1 (0.9)

Azithromycin+ Oseltamivir+ Meropenem/ Sulbactam+
Piperacillin/ Tazobactam
Azithromycin+ Cefuroxime+ Oseltamivir+ Piperacillin/
Tazobactam
Amoxicillin/ Clavulanic Acid+ Ciprofloxacin

1 (0.9)

Amoxicillin/ Clavulanic acid+ Clindamycin+ Ciprofloxacin+
Metronidazole+ Piperacillin/Tazobactam+ Tinidazole

1 (0.9)

Ceftriaxone+ Clindamycin
Clindamycin+ Fluconazole+ Linezolid+
Meropenem/Sulbactam+ Oseltamivir
Azithromycin+ Piperacillin / Tazobactam
Azithromycin + Cefuroxime
Ceftriaxone+ Meropenem / Sulbactam
Ceftriaxone+ Cefoperazone / Sulbactam

1 (0.9)
1 (0.9)

1 (0.9)
1 (0.9)
1 (0.9)

1 (0.9)

1 (0.9)
1 (0.9)

3 (2.6)
1 (0.9)
1 (0.9)
2 (1.7)
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Azithromycin+ Amoxicillin/ Clavulanic acid+ Levofloxacin

1 (0.9)

Clindamycin+ Linezolid+ Piperacillin/ Tazobactam

1 (0.9)

Amikacin+ Ceftriaxone+ Piperacillin / Tazobactam

1 (0.9)

Imipenem/ Cilastatin+ Linezolid+ Minocycline+ Oseltamivir+
Piperacillin/ Tazobactam+ Sulfamethoxazole/ Trimethoprim

1 (0.9)

Azithromycin+ Ceftriaxone+ Meropenem/ Sulbactam

1 (0.9)

Cefoperazone/ Sulbactam+ Teicoplanin+ Vancomycin

1 (0.9)

Azithromycin+ Linezolid+ Piperacillin / Tazobactam

1 (0.9)

Sulfamethoxazole/ Trimethoprim
Azithromycin+ Ceftriaxone+ Itraconazole+ Linezolid+
Piperacillin/ Tazobactam
Azithromycin+ Meropenem/ Sulbactam+ Piperacillin/
Tazobactam
Meropenem/ Sulbactam
Cefoperazone/ Tazobactam
Ceftriaxone+ Ceftazidime
Doxycycline+ Meropenem+ Teicoplanin+ Piperacillin/
Tazobactam
Cefoperazone/ Sulbactam+ Metronidazole

1 (0.9)
1 (0.9)

Cefoperazone/Sulbactam+ Clindamycin
Cefazolin
Ceftriaxone+ Sulfamethoxazole+ Trimethoprim

1 (0.9)
1 (0.9)
1 (0.9)

Azithromycin+ Ceftriaxone+ Piperacillin/ Tazobactam+
Meropenem/ Sulbactam

1 (0.9)

1 (0.9)
2 (1.7)
1 (0.9)
1 (0.9)
1 (0.9)
1 (0.9)

4.6 Antimicrobials with Potential to Develop Adverse Mental Health in
Geriatrics
Total 178 antimicrobial agents with potential to develop adverse mental health were
prescribed in 89 geriatric patients. This comprises 21 antimicrobial drugs from various
classes of antimicrobial agents.

Majority of the patients were prescribed with Piperacillin/ Tazobactam (40; 22.5%) and
Azithromycin (40; 22.5%), followed by Oseltamivir (22;12.4 %) and other antimicrobials
[Table 6].
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Table 6: Antimicrobial Prescription with Potential to Develop Adverse Mental Health in
Geriatrics
Sl. No.

Antimicrobial agents

No. of Antimicrobial Agents

1.

Amoxicillin/ Clavulanic acid

08 (4.5 %)

2.

Piperacillin/ Tazobactam

40 (22.5 %)

3.

Doxycycline

09 (5.1 %)

4.

Minocycline

01 (0.6 %)

5.

Cefazolin

02 (1.1 %)

6.

Cefepime

01 (0.6 %)

7.

Ceftazidime

01 (0.6 %)

8.

Cefuroxime

12 (6.7 %)

9.

Ciprofloxacin

02 (1.1 %)

10.

Levofloxacin

03 (1.7 %)

11.

Azithromycin

40 (22.5 %)

12.

Sulfamethoxazole/Trimethoprim

03 (1.7 %)

13.

Imipenem/ Cilastatin

02 (1.1 %)

14.

Meropenem/ Sulbactam

13 (7.3 %)

15.

Linezolid

06 (3.4 %)

16.

Metronidazole

06 (3.4 %)

17.

Isoniazid

02 (1.1 %)

18.

Rifampin

02 (1.1 %)

19.

Ethambutol

02 (1.1 %)

20.

Fluconazole

01 (0.6 %)

21.

Oseltamivir

22 (12.4 %)

4.7 Combination of Antimicrobials with Potential to Cause Adverse Mental
Health in Geriatrics
Out of 115 geriatric patients, 89 (77.4%) patients received antimicrobial agents with potential
to cause adverse mental health while 26 (22.6%) patients did not receive such drugs.
The geriatric patients were prescribed these antimicrobial agents as monotherapy 43 (37.4%)
or in combination. [Table 7].
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Table 7: Combination of Antimicrobials with Potential to Cause Adverse Mental Health
in Geriatrics
No. of drugs in combination of Antimicrobials

No. of Patients (%)

No antimicrobial agent

26 (22.6%)

Single Antimicrobial agent

43 (37.4%)

Two Antimicrobial agents

18 (15.7%)

Three Antimicrobial agents

18 (15.7%)

Four Antimicrobial agents

06 (5.2%)

Five Antimicrobial agents

03 (2.6%)

Six Antimicrobial agents

01 (0.9%)

4.8 Prevalence of Adverse Mental Health in Geriatrics
Out of 115 geriatric patients, 10 (8.7%) patients developed adverse mental health after taking
the prescribed antimicrobial agents, while 105 (91.3%) patients did not develop ADR [Figure
3].

Figure 3: Prevalence of Adverse Mental Health in Geriatrics
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4.9 Antimicrobial Prescriptions with potential to cause adverse mental
health in geriatrics
Out of total 115 patients, 89 (77.4%) geriatric patients received antimicrobial agents which
have the potential to develop adverse mental health [Table 8].
Table 8: Number of Antimicrobial Prescriptions with Potential to Cause Adverse
Mental Health in Geriatrics
Antimicrobial prescriptions with potential to
cause adverse mental health in geriatrics
Yes

No. of Patients

No

89 (77.4%)

26 (22.6%)

4.10 Antimicrobial Prescriptions with Adverse Mental Health in Geriatrics
Out of 89 geriatric patients who received antimicrobial agents which have potential to cause
adverse mental health issues, 10 (11.24%) patients developed the ADRs [Figure 4].

10 (11.2)

No. of patients who developed
ADR
No. of patients who did not
develop ADR

79(88.8%)

Figure 4: Geriatric Patients with Adverse Mental Health After Antimicrobial Use
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4.11 Antimicrobial Agents and the Developed Adverse Mental Health in
Geriatrics
Six antimicrobial agents caused the adverse mental health in 10 (11.24%) geriatrics patients
among 89 patients who received antimicrobial agents with potential to cause adverse mental
health effects.
Out of these 10 patients, 8 patients developed adverse mental health due to single drug, while,
2 patients developed with two and three adverse effects respectively, due to combination of
antimicrobial agents [Table 9].
Table 9: Antimicrobial Agents and the Developed Adverse Mental Health in Geriatrics
Antimicrobial agents

Adverse Mental Health

No. of Patients

Azithromycin

Insomnia

2 (2%)

Azithromycin

Agitation

1 (1%)

Metronidazole

Insomnia

2 (2%)

Piperacillin/ Tazobactam

Insomnia

1 (1%)

Piperacillin/ Tazobactam

Delirium

1 (1%)

Oseltamivir

Anxiety

3 (3%)

Oseltamivir

Nightmares

1 (4%)

Doxycycline

Insomnia

1 (1%)

Meropenem/ Sulbactam

Seizures

1 (1%)

4.12 Antipsychotic Drugs Prescribed for Adverse Mental Health
Out of 89 geriatric patients, 10 (11.24%) patients developed adverse mental health. Of these,
4 patients received antipsychotic drugs for treatment of adverse mental health related to
antimicrobial agents [Table 10].
Table 10: Antipsychotic Drugs Prescribed for Adverse Mental Health
Adverse Mental Health

Antipsychotic drug

Insomnia

Alprazolam, Zolpidem

Delirium

Quetiapine

Seizures

Lorazepam
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4.13 Average Number of Antimicrobial Agents per Prescriptions
In our geriatric patients, average number of antimicrobials per prescription is 2.3.

4.14 Average Number of Antimicrobial Agents per Prescriptions with
Potential to Cause Adverse Mental health
In our geriatric patients, average number of antimicrobials per prescription, which has the
potential to cause mental health adverse effect is 1.5.

4.15 Risk estimation for development of the Adverse Mental Health with
Gender
In our study, 10 patients developed ADR, out of which 8 (12.5%) were females and 2
(3.9%) were male.
Table 11: Association between Gender and Adverse Mental Health
Gender

ADR

No ADR

Total

Female

8 (12.5%)

56 (87.5%)

64 (100%)

Male

2 (3.9 %)

49 (96.1%)

51 (100%)

Total

10 (8.7%)

105 (91.3%)

115 (100%)

Risk estimation
OR: 3.5
95%CI:0.71-17.27

Female geriatric patients have 3.5 times higher risk for developing the adverse mental health
problems compared to male patients after the antimicrobial use (OR: 3.5; 95%CI:0.06-1.41)
[Table 11]

4.16 Risk estimation for development of the Adverse Mental Health with
Renal Dysfunction
Table 12: Association between Renal Dysfunction and Adverse Mental Health
Renal

ADR

No ADR

Total

Risk estimation

dysfunction
Yes

1 (6.7 %)

14 (93.3 %)

15 (100%)

No

9 (9.0 %)

91 (91.0 %)

100 (100%)

Total

10 (8.7%)

105 (91.3%)

115 (100%)

OR: 0.28
95%CI:0.08-6.15
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The risk for development of adverse mental health problems in patients with renal
dysfunction are 28% times less likely than the patients with normal renal function (OR:
0.28; 95%CI:0.08-6.15) [Table 12]. This may be because number of patients with renal
dysfunction in our study population is very small.
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5. DISCUSSION
A cross-sectional study was conducted in Kasturba Hospital, Manipal to evaluate antimicrobial
agents with potential to develop adverse mental health in geriatrics. This study comprised of
115 geriatric patients (age 65 years and above) prescribed with antimicrobial agents. Informed
consent was obtained from the patients or legally authorized representatives (unresponsive
patients). The data was collected from the medical records and the direct patients interview
form all the Medicine units of the hospital. In our knowledge, not much studies are performed
on mental health, especially on the drug-induced adverse mental health in Indian population.
In our study, the age of the patients was 65 years and above, as it involved only geriatric
patients. The mean age of our study population was found to be 71.90 ± 6.186 years. According
to a randomized controlled trial (RCT) by Avni et al (8), no RCT reported exclusion based on
an upper age limit in geriatric trials. Mattappalil et al

(4)

have suggested that the risk of

developing neurotoxicity symptoms was more in elderly patients due to various age-related
changes.
This study included total of 115 patients, out which 51 (44.3%) were male and 64 (55.7%) were
female. The number of female patients is higher than male as female wards were visited more
than the male wards for data collection. The mean duration of hospitalization for this study was
found to be 11.82 ± 6.96 days. There was no significant relation found between increased
duration of hospitalization and occurrence of adverse drug reactions (ADRs). Also, alcoholism
and smoking had no significant effect on occurrence of ADRs. The mean number of comorbidities found in our study population was 1.74 ± 1.33.
Respiratory tract infections such as pneumonia (25; 21.73%) and LRTI (21; 18.26%) were most
common conditions for prescription of antimicrobial agents. The second most common
condition was UTI (11;9.56%) and urosepsis (9; 7.82%), followed by suspected infections (13;
11.3%) and other conditions (36; 31.3%). Apisarnthanarak A, et al.

(9)

also reported almost

similar finding where RTI were the most common conditions leading to antibiotic prescription.
The second most common condition was UTI followed by gastrointestinal tract infections,
fever and suspected tract infections and others.
The average number of antibiotics per prescription is an important index of the scope for review
and educational intervention in prescribing habits. In this study, the average number of
antibiotics per prescription was found to be 2.3. Based on result of prescription analysis, most
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of the patients received monotherapy (39;33.9%), followed by 2 antimicrobial agents (34;
29.6%), 3 antimicrobial agents (25;21.7%) and more than 3 antimicrobial agents (7; 14.7 %).
Similar result was reported by Bist et al. (10), where monotherapy (60%), 2 drugs (27%), 3 drugs
(11.06%), 4 drugs (1.40%) received by study participants.
The indications for antimicrobial use was divided into two empiric and definitive. Prescriptions
were considered empiric if: (a) it was mentioned in medical record as empiric treatment, (b) an
infectious disease was diagnosed, (c) clinical signs and symptoms of infection such as fever
were present on the day of starting antimicrobial therapy. Prescriptions were considered as
definitive if: (a) it was mentioned in medical record, (b) antimicrobial agents were initiated
after culture test. In our study, out of total 115 geriatric patients, 45 (39.1%) patients received
empirical antimicrobial agents while, 70 (60.9%) received definitive treatment of antimicrobial
agents based on their diagnosis. Apisarnthanarak et al.

(9)

analysed the impact on five reasons

for inappropriateness of prescribing antibiotics. These include inappropriate surgical
prophylaxis, use of antibiotic without any evidence of infection, redundant spectrum, bacterial
resistance and narrow spectrum was available. Warstler et al (3) observed that the antimicrobial
induced adverse mental health is supported by limited number of case reports and case series.
Data from large, randomized-controlled studies are lacking.
A checklist of antimicrobial agents which have potential to develop adverse mental health
issues in geriatrics was prepared [Table 1]. Out of total 115 patients in our study, 89 (77.4%)
geriatric patients received antimicrobial agents which have the potential to develop adverse
mental health. Of these 89 patients, 10 (11.24%) patients developed adverse mental health
effects. On an average, 1.5 antimicrobial agent with potential to cause ADR was prescribed per
prescription. Majorly prescribed antimicrobials with potential to cause adverse mental health
in the study population were Piperacillin/ Tazobactam (40; 22.5 %) among the beta-lactam
class, Azithromycin (40; 22.5 %) among the macrolide class, Oseltamivir (22; 12.4 %) among
the antiviral class, Meropenem/Sulbactam(13; 7.3%) among the carbapenem class and
Cefuroxime (12; 6.7%) among the cephalosporin class.
Total 178 antimicrobial agents with potential to develop adverse mental health were prescribed
in 115 geriatric patients. These included 21 drugs from different class of antimicrobial agents.
In the beta-lactam class, Amoxicillin/ Clavulanic acid 08 (4.5%) and Piperacillin/ Tazobactam
40 (22.5%) were present. Mattappalil et al reported that although beta-lactams are considered
as safe for administration on geriatrics, but the neurotoxicity with Penicillin/ Tazobactam is
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more prevalent in geriatrics as per a review article

(4)

. According to a systematic review by

Sutter et al (11), Piperacillin/ Tazobactam has been reported to cause seizures in patients with
renal insufficiency. Among the tetracycline class of antimicrobials were Doxycycline (9; 5.1%)
and Minocycline (1; 0.6%). According to a case report by Atigari et al (12), two of three patients
committed suicide while on Doxycycline treatment. While Shamout et al (13) presents a case of
a female diagnosed with perioral dermatitis treated with Minocycline developed severe
depersonalization symptoms within 1 week after initiation of the drug.
Among the cephalosporin class of antimicrobials there were four drugs namely, Cefazolin (02;
1.1%), Cefuroxime (12; 6.7%), Ceftazidime (1; 0.6%) and Cefepime (1; 0.6%). Grill et al (14)
reported neurotoxicity with first-generation (e.g. cefazolin), second generation (e.g.
cefuroxime), third generation (e.g. ceftazidime) and fourth generation (e.g. cefepime)
cephalosporins. These adverse effects range from encephalopathy to non-convulsive status
epilepticus. A systematic review by Payne et al

(15)

revealed 135 patients who received

cefepime exhibited altered mental status with declined consciousness (47%), myoclonus
(42%), and confusion (42%). Another systematic review by Sutter et al

(11)

found

cephalosporins have been reported to cause seizures in patients with renal insufficiency.
Ciprofloxacin (2;1.1%) and Levofloxacin (3; 1.7%) were among the fluoroquinolones. Sellick
et al (16) suggested that delirium or psychosis occurred in 3.6% (n=23) of the study population
due to Ciprofloxacin. Tome et al (17) found out of 111 ADRs, common were mania (38 cases),
insomnia (10 cases), acute psychosis (8 cases), delirium (8 cases), seizures (23 cases) and
confusion (9 cases) due to Ciprofloxacin, while, Levofloxacin caused delirium (8 cases).
Azithromycin (40; 22.5%) was one of the majorly prescribed antimicrobial agents among the
macrolide class. Cone et al (18) reported two geriatric patients (aged 78 years and 88 years) have
developed delirium within 72 hours after initiating Azithromycin therapy. The symptoms lasted
48 to 72 hours after discontinuing the drug. Sulfonamides class SulfamethoxazoleTrimethoprim 03 (1.7%) was one of the potent antimicrobial agents prescribed to these patients.
Gregor et al

(19)

reported that a 74-year-old woman developed visual hallucinations and

delusions over a six-day period after oral administration of the drug for UTI. After 60 hours of
discontinuation of drug, her mental functioning returned to normal. Another case report by
Stuhec

(20)

found that an 86-year-old woman developed hallucinations when treated with

sulfamethoxazole-trimethoprim for UTI.
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Among the carbapenem class, two drugs were prescribed namely, Imipenem-Cilastatin (2;
1.1%) and Meropenem/Sulbactam (13; 7.3%). A systematic review by Sutter et al (11) reported
Imipenem found to be more seizure-inducing than meropenem. Linezolid (6; 3.4%) belongs to
Oxazolidinone class of antimicrobial agents. Mattappalil et al

(4)

found incidence of

neurotoxicity with linezolid is low (0.36%), whereas, encephalopathy and delirium incidence
are high.
Other antibiotics such as Metronidazole (6 ;3.4%), Isoniazid (2; 1.1%), Rifampin (2; 1.1%),
and Ethambutol (2; 1.1%) were also prescribed. Papathanasiou et al (21) published a case report
with a 62-year-old male who developed reversible encephalopathy due to Metronidazole, while
Kim et al

(22)

published a case of 71-year-old Asian man developed encephalopathy post

metronidazole therapy for infectious colitis. A review article by Zareifopoulos

(23)

suggested

that though many cases of Isoniazid-induced mania or toxic psychosis have been reported but
it is not likely to be mediated by specific action of the drug in the CNS. Denholm et al

(24)

reported that 9 patients developed cognitive impairment, 1 patient reported of sleep
disturbance, while 1 patient reported to have developed psychosis, paranoia and hallucination
after a month of initiating the Isoniazid therapy. A review article by Zareifopoulos et al

(25)

suggested that incidents of Rifampin-induced neurotoxicity are reported but are rare. Incidents
of ethambutol induced psychosis and mania are also reported.
Among the antifungal class of antimicrobial agents, only Fluconazole (1; 0.6%) was prescribed
in the study population. Matsumoto, et al (25) published two case reports of Fluconazole induced
seizures in a 66-year-old woman and 62-year-old man, respectively. Besides, Govindarajan et
al (26) reported Fluconazole- induced seizures, insomnia, and somnolence.
Among the antiviral class of drug, only Oseltamivir (22;12.4%) was prescribed in the study
population. Chen R, et al

(27)

published a case report with 57-year-old female suffered from

hallucinations, delirium and unusual behaviour following Oseltamivir therapy, but recovered
completely after cessation of the therapy.
The antimicrobial agents with potential to develop adverse mental health in geriatrics were
prescribed as monotherapy (43; 37.4%) or in combinations like 2 drugs (18 ;15.7%), 3 drugs
(18;15.7%), more than 3 drugs (10;8.7%). On an average, 1.5 antimicrobial agent with potential
to cause adverse mental health was prescribed per prescription.
The 10 patients who developed the adverse effects were prescribed with Azithromycin
(insomnia= 2, agitation = 1), Metronidazole (insomnia = 2), Piperacillin-Tazobactam
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(insomnia = 1, delirium =1), Oseltamivir (anxiety = 3, nightmare = 1), Doxycycline (insomnia
=1), Meropenem-Sulbactam (seizures = 1). Out of these 10 patients who developed adverse
mental health, 3 patients received anti-psychotic drugs such as Alprazolam and Zolpidem for
insomnia, Quetiapine for delirium and Lorazepam for seizures.
Risk estimation shows that female geriatric patients have 3.5 times higher risk for developing
the adverse mental health problems compared to male patients after the antimicrobial use.
Rademaker, (2001) reported that female has 1.5 to 1.7 times higher of developing an ADR than
male

(28)

. This may be due to gender differences in hormonal as well as immunological

physiology that modulate PK/PD response

(29)

. Unlike other studies the risk for development

of adverse mental health problems in patients with renal dysfunction are 2.8 times less likely
than the patients with normal renal function.
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6. CONCLUSION
The study concludes that majority of geriatric patients were prescribed antimicrobial agents
that have potential to develop adverse mental health issues. The geriatric population is already
at a greater risk of developing drug induced neuropsychiatric adverse effects due to various
age-related factors. It is also important to note that majority of antimicrobial agents induced
neuropsychiatric or adverse mental health problems are supported by case reports or case series
only. Data from large, randomized-controlled studies are lacking. Not many studies have been
performed on the drug-induced mental health in Indian population. However, various
antimicrobial classes are involved in adverse mental health issues in geriatrics such as betalactams,

tetracyclines,

cephalosporins,

fluoroquinolones,

macrolides,

sulfonamides,

aminoglycosides, carbapenems, oxazolidines, other antibiotics, antifungals, antimalarial and
antivirals. Risk estimation shows that women geriatric patients have higher risk for developing
the adverse mental health problems compared to men after the antimicrobial use. However,
unlike other studies renal dysfunction was not found to be a risk factor for developing the
adverse mental health. Potential mechanism of toxicity differs among the agents and the
etiology also remains unidentified in some cases. Incidence of adverse mental health is
increased due to presence of co-morbidities or drug interaction. Therefore, prior to prescribing
these antimicrobial agents, certain aspects should be taken into consideration such as drug
dosing, co-morbidities, concurrent medication use and baseline clinical characteristics. Use of
antimicrobial agents without concern for age-related alterations potentiates the risk of adverse
mental health in geriatric patients. Awareness of antimicrobials contributing to
neuropsychiatric events may enhance clinical decisions in diagnosis and management when
such incidents occur.
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LIMITATIONS
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7. LIMITATIONS
a) We have included cases from only medicine units of Kasturba Medical College
Hospital since the infectious disease cases are admitted mainly in medicine units.
b) Not all the drugs included in the checklist were observed due to decreased prescribing
of those drugs in our hospital.
c) The ADRs are not reported in the medical records for most of the patients and the
patients are also not aware about the unusual symptoms or do not share the same with
physicians due to social stigma.
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Appendix II a: Participant Information Sheet (English)
PARTICIPANT INFORMATION SHEET
Project title: Evaluation of antimicrobial agents with potential to develop adverse mental
health in geriatrics
IEC No.: 588/2019
Sponsor Name:
Language: English
Principal Investigator: Vaishali V. Shinde
Designation: 2nd year Pharm-D (PB)
Hospital: Kasturba Medical College Hospital, Manipal
Mobile number: 8108134431
Please read this form carefully. If you don't understand the language or any information in
this document, please discuss with study doctor. Your participation in this study is
voluntary, and you can enquire about all details before giving your written consent to
participate in this study.
1. Introduction to the research study:
You are invited to participate in this study because you belong to geriatric age group who
have been prescribed antimicrobials.
2. Purpose of the study:
The purpose of this study is to:
(a) To prepare a checklist of drugs as per the hospital formulary, which have the potential
to cause adverse mental health.
(b) Evaluate the geriatric antimicrobial prescription to determine its potential to cause
mental health issue.
(c) To identify antimicrobial related mental health problems in geriatric patients.
3. Who can take part:
Inclusion criteria:

•
•
•

Geriatric patients
Patients of both gender
Patients receiving antimicrobial drugs

Exclusion criteria:

•
•

Geriatric patients who have not been prescribed antimicrobial drugs
Other than geriatric population
 Patients who have psychiatric disorder or on anti-psychotic drugs
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4. Information about the study (as a whole):
300 geriatric patients admitted in the medicine units of KMC hospital, who have been
prescribed antimicrobial drugs will be included in the study. The prescriptions will be
evaluated by the investigator and checked for antimicrobial drugs that have potential to
cause adverse mental health. The study period is of one year.
5. What will happen to you (the individual participant) during the study:
Since it is an observational study, the prescriptions will be evaluated from your patient
medical file. Also, please provide information as enquired by the investigator or physician.
Your identity will remain confidential. The approximate time taken for the data collection
would be 30 minutes. The prescriptions will be evaluated as per geriatric guidelines and
checked for antimicrobials which have potential to cause adverse mental health.

6. Your (the individual participant) role/responsibility in the study:

•
•

Provide accurate information whenever asked.

•

If you want to discontinue from the study, study doctor to be informed.

Inform the study doctor about any problem/side effects experienced during the
study.

7. What are the risks?
Since this is an observational study, only a minimal risk is involved.
8. What are the potential benefits of participating in the study:
You may or may not get benefit from participating in this study. It is possible that you may
get better, stay the same, or get worse. If you take part in this study you may help other
patients by helping to collect evidence of drugs that can cause potential adverse mental
health issues in geriatric population, thereby, by contributing to the knowledge on the drugs
prescribed for geriatric patients.
9. What are the alternative treatments available?
Since the study is observational in nature, study does not influence any treatment.
10. Cost of participating in the study:
No additional costs for being a part of the study.
11. Compensation for injury:
Since this is an observational study, no medical problem will arise due to this study.
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12. Confidentiality of information:
Information from the study records including your name, address, medical records, results of
tests, study results will be kept confidential and will be reviewed only by authorized personnel
from the sponsor or their representative, Ethics Committee or regulatory bodies. The data will
not be made available to another individual unless you specifically give permission in writing.
Information and results from this study may be presented at meetings or published in journals
without including your name and personal identifications. No reference will be made in oral
or written reports which could link you to the study.
13. New information about the study:
Any new information available during the course of the study will be informed to you if it has
relevance to your decision regarding continuing in the study. Results of your participation
will be disclosed to you if you indicate your desire for it.
14. Voluntary participation:
Your participation in this study is voluntary; you may decline to participate at any time and
you need not give any reason for the same, and such withdrawal shall be without penalty and
without loss of benefits to which you are otherwise entitled. If you withdraw from the study
prior to its completion, you will receive the usual standard of care for your disease, and your
non-participation will not have any adverse effects on your subsequent medical treatment or
relationship with the treating physician.
If you withdraw from the study before data collection is completed, your data collected until
you indicated withdrawal will be used in the study report. Sponsor or the investigator may
stop the research or your participation in it at any time for some or other reason without your
permission.
15. Whom to contact in case of any questions:
If you experience adverse effects as a result of participating in this study, you may contact
the Principal Investigator (Vaishali V. Shinde) as detailed above.
If you have any questions about the informed consent process or your rights as a participant,
you may contact the Member Secretary of the Kasturba Medical College and Kasturba
Hospital - Institutional Ethics Committee at Room 22, Ground floor, KMC Faculty Rooms,
adjacent to KMC Administrative Block, Kasturba Medical College, Manipal - 576104.
Phone: 0820 29 33522. Timings: 9:00 AM to 5:00 PM.
If you have any questions about this form or any study related issue, you may also contact
the following person.
Name Dr. Rajesh V.
Address Department of Pharmacy Practice, MCOPS, Manipal
Telephone No. +919538417313
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Appendix II b: Participant Information Sheet (Kannada)
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Appendix III a: Informed Consent Form (English)
INFORMED CONSENT FORM
Project title: Evaluation of antimicrobial agents with potential to develop adverse mental
health in geriatrics
I confirm I have read the Participant Information Sheet for the above study and its contents
were explained and I have had the opportunity to ask questions and received satisfactory
answers.
I understand that my participation in the study is voluntary and that I have the right to
withdraw at any time without giving any reason, without my medical care or legal rights
being affected.
I agree to take part in the above study. I confirm that I have received a copy of the
Participant Information Sheet along with this signed and dated informed consent form.
Name of the Research Participant.:
Age of the Research Participant:
Address of the Research Participant:
Occupation.:
Annual Income of the Participant:
Name & address of the nominee(s) and his relation to the Participant:

Signature of the research subject

Date

Name & Signature of the witness

Date

Name & Signature of the person explaining the consent

Date
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Appendix III b: Informed Consent Form (Kannada)
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Appendix IV: Case Report Form
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